european network for adrenal tumors

 

latest news from ens@t

  • 13 Sep 2017 11:50 | Silviu Sbiera (Administrator)

    Thanks to the Paradifference Foundation, we will have this year two additional awards dedicated to malignant pheochromocytoma and paraganglioma. Applicable research topics will comprise scientific work on malignant pheochromocytoma and paraganglioma relevant to the pathophysiology, genetics, epidemiology, diagnosis or therapy of the disease. There are two awards (€ 1250,- each). Deadline for applications is October 15th 2017. To see more details about how to apply please click here.


    About the Paradifference Foundation. The Gustavsson family founded the Paradifference Foundation in February 2014. Their eldest daughter Amanda developed her first paraganglioma tumor in 2008, and today it has spread to her bones (metastatic paraganglioma). Since 2011 they know that this is caused due to the SDHB mutation. The foundation describes their aim as follows: Our aim is to financially support research in the field of paraganglioma and pheochromocytoma, with special regard to malignant paragangliomas caused by the SDHB mutation.  We hope to aid in the development of more efficient treatment, and essentially finding a cure for the disease. As part of this aim, we want to encourage young scientists to conduct research within the field, and want to ensure that promising scientists are enabled a career within paraganglioma research. Therefore we have decided to fund these awards.

  • 05 Sep 2017 14:36 | Silviu Sbiera (Administrator)

    Applicable research topics will comprise scientific work on any type of adrenal tumors in four categories relevant to the pathophysiology, genetics, epidemiology, diagnosis or therapy of the disease. There are four awards (€ 2000,- each), one for research on Adrenocortical Carcinoma (ACC), one for Pheochromocytoma and Paraganglioma (Pheo/PGL), one for Aldosterone Producing Adenoma (APA) and one for Non-Aldosterone Producing Adrenocortical Adenoma (NAPACA), respectively. To see more details about how to apply please click here.

    In addition, thanks to the Paradifference Foundation, we will have an additional award dedicated to malignant pheochromocytoma and paraganglioma. Details about this prize will be posted shortly.

    Deadline for all applications is September 4th.

  • 24 Aug 2017 00:00 | Silviu Sbiera (Administrator)
    16th ENSAT Scientific Meeting, 16-17 November 2017, Paris, France

    Please click here for more informations

  • 06 Apr 2017 11:16 | Silviu Sbiera (Administrator)

    The 15th ENS@T scientific meeting was held at the University of Birmingham and chaired by Wiebke Arlt.
    Attendees came from 22 countries to participate in the two day conference, which began on  the Friday at the Everyman Cinema, Mailbox, where there was a packed programme of oral presentations.  Delegates enjoyed networking in the evening  at the Festive Awards Dinner in the Banqueting Suite, Council House, Birmingham.
    Day 2 was held at the Medical School, University of Birmingham and consisted of working groups, oral communications and guided poster sessions.  There was also  a parallel patient strand programme in collaboration with ACC Support UK. Patients attending this meeting were given the opportunity to join the conference for some of the sessions.
    The meeting is entirely submission-driven and science from the whole of Europe and beyond was presented, focussing on the four different entities, non-aldosterone producing adrenocortical adenoma (NAPACA), adrenocortical carcinoma (ACC), phaeochromocytoma (PHAEO) and primary aldosteronism (APA).
    In addition to ENSAT, the conference was supported by the European Society of Endocrinology, HRA Pharma, Millendo Therapeutics and Alta Bioscience.


    Photos from the 2016 ENS@T Meeting in Birmingham can be now found here

  © ENS@T - European Network for the Study of Adrenal Tumors 2002 - 2012
Powered by Wild Apricot Membership Software